Despite the largest U.S. pharmacy…
Despite the largest U.S. pharmacy benefit manager knocking Zepbound off [...]
Takeda has given up on an…
Takeda has given up on an AstraZeneca-partnered neurological disorder program [...]
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
The agency announced moves to cut regulatory obstacles for the [...]
Roche’s Genentech unit is laying…
Roche’s Genentech unit is laying off staff at its Bay [...]
The FDA has revealed a set of…
The FDA has revealed a set of measures designed to [...]
AbbVie has scrapped an asset from…
AbbVie has scrapped an asset from its ongoing collaboration with [...]
Novartis is pulling back the…
Novartis is pulling back the curtain on late-stage Sjögren’s wins, [...]
After a progression-free survival…
After a progression-free survival win last year raised hopes for [...]
Eli Lilly and computing giant…
Eli Lilly and computing giant Nvidia are teaming up to [...]
Texas Sues Tylenol Makers, Claiming They Hid Autism Risks
The lawsuit follows claims by President Trump that linked use [...]